Lilly (Eli) & Co. Business Finance Contracts & Agreements
73 Contracts & Agreements
- Indenture Agreements (5 contracts)
- Note Agreements (17)
- Release Agreements (1)
- Shareholders Agreements (4)
- Stock Agreements (33)
- Underwriting Agreements (13)
- Underwriting Agreement, dated February 23, 2023, among Eli Lilly and Company and J.P. Morgan Securities LLC, Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. LLC and Morgan... (Filed With SEC on February 24, 2023)
- Form of Officers Certificate setting forth the terms and form of the Notes (Filed With SEC on February 24, 2023)
- Form of Shareholder Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 22, 2023)
- Form of Relative Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 22, 2023)
- Form of Shareholder Value Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on November 1, 2022)
- Form of Relative Value Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on November 1, 2022)
- Description of the Company's 0.500% Notes due 2033, 1.125% Notes due 2051, and 1.375% Notes due 2061 (Filed With SEC on February 23, 2022)
- Description of the Company's 1.625% Notes due 2043 (Filed With SEC on February 23, 2022)
- Form of Shareholder Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 23, 2022)
- Form of Shareholder Value Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on February 23, 2022)
- Form of Shareholder Value Award under the 2002 Lilly Stock Plan (non-executive officer) (Filed With SEC on February 23, 2022)
- Form of Relative Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 23, 2022)
- Form of Relative Value Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on February 23, 2022)
- Form of Relative Value Award under the 2002 Lilly Stock Plan (non-executive) (Filed With SEC on February 23, 2022)
- Form of Restricted Stock Unit Award under the 2002 Lilly Stock Plan (Filed With SEC on February 23, 2022)
- Underwriting Agreement, dated September 8, 2021, among Eli Lilly and Company and Merrill Lynch International, Barclays Bank PLC, BNP Paribas, Citigroup Global Markets Limited and... (Filed With SEC on September 10, 2021)
- Form of Officers Certificate setting forth the terms and form of the Notes (Filed With SEC on September 10, 2021)
- Form of Restricted Stock Unit Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on April 30, 2021)
- Release Agreement, effective as of February 9, 2021, by and between Eli Lilly and Company and Joshua L. Smiley (Filed With SEC on April 30, 2021)
- Form of Shareholder Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 17, 2021)
- Form of Shareholder Value Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on February 17, 2021)
- Form of Shareholder Value Award under the 2002 Lilly Stock Plan (non-executive officer) (Filed With SEC on February 17, 2021)
- Form of Relative Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 17, 2021)
- Form of Relative Value Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on February 17, 2021)
- Form of Restricted Stock Unit Award under the 2002 Lilly Stock Plan (Filed With SEC on February 17, 2021)
- Underwriting Agreement, dated August 20, 2020, among the Company and BNP Paribas Securities Corp., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Morgan Stanley &... (Filed With SEC on August 21, 2020)
- Form of Officers Certificate setting forth the terms and form of the 2060 Notes and certain matters with respect to the New 2050 Notes (Filed With SEC on August 21, 2020)
- Underwriting Agreement (Filed With SEC on April 28, 2020)
- Form of Officers Certificate setting forth the terms and form of the Notes (Filed With SEC on April 28, 2020)
- Description of the Company's Common Stock (Filed With SEC on February 19, 2020)
- Description of the Company's 1.000% EUR Notes due 2022, 1.625% EUR Notes due 2026, and 2.125% EUR Notes due 2030 (Filed With SEC on February 19, 2020)
- Description of the Company's 6.77% Notes due 2036 (Filed With SEC on February 19, 2020)
- Description of the Company's 7 1/8% Notes due 2025 (Filed With SEC on February 19, 2020)
- Description of the Company's 0.625% EUR Notes due 2031 and 1.700% EUR Notes due 2049 (Filed With SEC on February 19, 2020)
- Form of Shareholder Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 19, 2020)
- Form of Relative Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 19, 2020)
- Restricted Stock Unit Award to Michael Harrington under the 2002 Lilly Stock Plan (Filed With SEC on February 19, 2020)
- Underwriting Agreement (Filed With SEC on November 6, 2019)
- Form of Officers Certificate setting forth the terms and form of the Notes (Filed With SEC on November 6, 2019)
- Underwriting Agreement (Filed With SEC on February 21, 2019)
